Abstract:You have accessJournal of UrologyKidney Cancer: Epidemiology & Evaluation/Staging III1 Apr 2017PD52-10 SHORTER TELOMERE LENGTH INCREASES AGE-RELATED TUMOR RISKS IN CHINESE VON HIPPLE-LINDAU DISEASE Jiangyi Wang, Shuanghe Peng, Xianghui Ning, Teng Li, Jiayuan Liu, Shengjie Liu, and Kan Gong Jiangyi WangJiangyi Wang More articles by this author , Shuanghe PengShuanghe Peng More articles by this author , Xianghui NingXianghui Ning More articles by this author , Teng LiTeng Li More articles by this author , Jiayuan LiuJiayuan Liu More articles by this author , Shengjie LiuShengjie Liu More articles by this author , and Kan GongKan Gong More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.2198AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Von Hipple-Lindau(VHL) disease is a rare autosomal dominant familial cancer syndrome with age relatived cancer onset in patients' life. The five common tumors are central nervous system (CNS) hemangioblastoma, renal cell carcinoma(RCC) ,retinal angioma(RA), pancreatic cyst and tumor(PCT), and pheochromocytoma(Pheo). Until now, no reliable markers are found to predict the age-related tumor risks in VHL patiens. The present study has evaluated the influence of peripheral leukocyte telomere length on age-related tumor risks in a large group of VHL patients. METHODS Genomic DNA was extracted from peripheral blood of 187 VHL patients. Tumor onset age was defined as the age when any symptom or imaging sign of the tumor first occurred. Age-related risks of the five tumors were evaluated using Kaplan-Meier plot and Cox regression model. Relative telomere length(RTL) was measured with qRT-PCR method. RESULTS The main death-causing tumor CNS hemangioblastoma occurred in 53.5%(100/187) VHL patients in our study, and the mean onset age was 30.2±11.3 years old. In the shorter RTL group(RTL<0.44), the first tumor onset age was 7.7 years earlier than the longer one(25.2±8.6y vs 32.9±12.3y, p<0.001). The shorter RTL group displayed a statistically higher age-related risks than the longer RTL group for CNS(HR1.99, p=0.001), RCC(2.02, p=0.0030), PCT(2.11, p<0.001) and Pheo(3.13, p=0.005). CONCLUSIONS We for the first time propose that peripheral leukocyte telomere length may be associated with risks of VHL-related tumors, which may be helpful for establishing personalized surveillance plan for VHL patients and for further understanding the pathogenesis of VHL disease. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e993 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Jiangyi Wang More articles by this author Shuanghe Peng More articles by this author Xianghui Ning More articles by this author Teng Li More articles by this author Jiayuan Liu More articles by this author Shengjie Liu More articles by this author Kan Gong More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

AB181. Telomere shortening is associated with genetic anticipation in Chinese Von Hippel-Lindau disease families

Telomere Shortening is Associated with Genetic Anticipation in Chinese Von Hippel-Lindau Disease Families.

Intra-familial Phenotypic Heterogeneity and Telomere Abnormality in Von Hippel-Lindau Disease

Shorter telomere length increases age-related tumor risks in von Hippel-Lindau disease patients.

MP67-01 TELOMERE LENGTH AND GENETIC ANTICIPATION IN A LARGE COHORT OF CHINESE VON HIPPLE-LINDAU DISEASE

Higher Prevalence of Novel Mutations in VHL Gene in Chinese Von Hippel-Lindau Disease Patients.

Genotype-phenotype Correlations in Chinese Von Hippel-Lindau Disease Patients

Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel-Lindau Disease.

Family History of Von Hippel–Lindau Disease Was Uncommon in Chinese Patients: Suggesting the Higher Frequency of De Novo Mutations in VHL Gene in These Patients

PD52-10 SHORTER TELOMERE LENGTH INCREASES AGE-RELATED TUMOR RISKS IN CHINESE VON HIPPLE-LINDAU DISEASE

AB110. the First Prenatal Diagnosis of Von Hippel-Lindau Syndrome in Chinese Mainland.

The Genotype-Phenotype Association Of Von Hipple Lindau Disease Based On Mutation Locations: A Retrospective Study Of 577 Cases In A Chinese Population

Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family

MP14-15 INTRA-FAMILIAL PHENOTYPIC HETEROGENEITY IN VON HIPPEL-LINDAU DISEASE: IMPLICATIONS FOR PERSONALIZED SURVEILLANCE PLAN

Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.

Clinical and Genetic Analysis of the Von Hippel-Lindau (VHL) Gene in Two Chinese Pedigrees with VHL Syndrome

AB175. the First Large-Scale Study of VHL Gene Mutation Spectrum and Genotype-Phenotype Correlationship of VHL Disease in China

p.N78S and p.R161Q germline mutations of the VHL gene are present in von Hippel-Lindau syndrome in two pedigrees.

Von-Hipple Lindau syndrome with family history: a case report and seventeen years follow-up study

Von Hippel-Lindau Disease Type 2 in a Chinese Family with a VHL P.w88x Truncation

Unexpected Information Of Dna Deletions In Genome: Analysis Of One Vhl Case With Array-Cgh